Isomorphic Labs raises $2.1 billion to advance AI-driven drug discovery

Insider Brief Lunar Outpost announced raising $30 million to expand production of lunar robotics and mobility systems. The Series B funding round was led by Industrious Ventures, with participation from Type One Ventures, Eniac Ventures, Promus Ventures and Reliable Equity, according to the company. The Colorado-based company develops robotic vehicles, mobility systems and infrastructure technologies […]

PALO ALTO, Calif., May 6, 2026 — DeepInfra, a purpose-built cloud platform for high-throughput AI inference, has announced $107 million in Series B funding to scale its inference cloud and […] The post DeepInfra Closes $107M Series B to Power Production-Scale AI Inference appeared first on AIwire.

Insider Brief PRESS RELEASE—Panthalassa, a renewable energy and ocean technology company, has announced $140 million in Series B financing led by Peter Thiel, with participation from new investors John Doerr, Marc Benioff’s TIME Ventures, Max Levchin’s SciFi Ventures, Susquehanna Sustainable Investments, Hanwha Asset Management (USA)’s venture fund, Anthony Pratt, Fortescue Ventures, Future Positive, WTI, Nimble […]

The LinkedIn cofounder now has an AI drug discovery startup—and thinks not asking chatbots for medical advice is “bordering on committing malpractice.”

Artificial intelligence is fundamentally rewiring how medicines are discovered, designed, and brought to market. The CEOs leading this transformation are compressing timelines that once took a decade into years, and in some cases, months. From generative protein design to AI-optimized clinical trials, these leaders are building the platforms that the world’s largest pharmaceutical companies now […]

Insider Brief Swiss industrial robotics company Kemaro has raised $5 million in an initial pre-closing of its Series B round. According to the company, the pre-closing was led by Spicehaus Partner AG with the Series B round targeting $20 million. Proceeds will go to bolstering sales operations, scaling international growth and new product development. Founded […]

10x Science, a startup using AI agents to automate the characterisation of drug candidates, has raised a $4.8 million seed round led by Initialized Capital, with backing from Y Combinator and Civilization Ventures. The company was founded in December 2025 by chemical biologist David Roberts, biologist Andrew Reiter, and serial founder Vishnu Tejus, all of […]

Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”